Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Bringing safe and effective cell therapies to the bedside.

Preti RA.

Nat Biotechnol. 2005 Jul;23(7):801-4. No abstract available.

PMID:
16003360
2.

The ability of current biologics law to accommodate emerging technologies.

Carter MJ.

Food Drug Law J. 1996;51(3):375-80. No abstract available.

PMID:
11797714
3.

Overview of FDA regulation of human cellular and tissue-based products.

Wells MA.

Food Drug Law J. 1997;52(4):401-8. No abstract available.

PMID:
10346672
4.

Cell transplantation and Federal regulation.

Noguchi PD.

Cell Transplant. 1995 Jul-Aug;4(4):411-4. Review.

PMID:
7582572
5.

Biotechnology and the food label: a legal perspective.

Degnan FH.

Food Drug Law J. 2000;55(3):301-10. No abstract available.

PMID:
11824462
6.

Modification and consumer information: modern biotechnology and the regulation of information.

Beales JH 3rd.

Food Drug Law J. 2000;55(1):105-17. No abstract available.

PMID:
12322718
7.

Informed consent and living human cells.

Maloney DM.

Hum Res Rep. 2002 Jul;17(7):3. No abstract available.

PMID:
12731490
9.

Global harmonization of regulatory requirements for premarket approval of autologous cell therapies.

Ward SM.

Food Drug Law J. 2000;55(2):225-43. No abstract available.

PMID:
12269366
10.

The US FDA and animal cloning: risk and regulatory approach.

Rudenko L, Matheson JC.

Theriogenology. 2007 Jan 1;67(1):198-206. Epub 2006 Oct 19. Review.

PMID:
17055042
11.

Is the Food and Drug Administration safe and effective?

Philipson TJ, Sun E.

J Econ Perspect. 2008 Winter;22(1):85-102. No abstract available.

PMID:
19728421
12.

Technology, medicine & health, Part 8. A new generation of transplant therapies.

Davidson SN.

Healthc Forum J. 1995 Nov-Dec;38(6):60-6. No abstract available.

PMID:
10151961
13.
14.

The regulation of biotechnologies: four recommendations.

Fox D.

Hastings Cent Rep. 2008 Mar-Apr;38(2):1 p following 56. No abstract available.

PMID:
18457229
15.

Prospects for application of biotechnology-derived biomaterials.

Hellman KB, Picciolo GL, Fox CF.

J Cell Biochem. 1994 Oct;56(2):210-24. No abstract available.

PMID:
7829583
16.

Truth in testing laws: a shot in the arm for designer gene tests.

van Voorhees A.

Health Matrix Clevel. 2006 Summer;16(2):797-829. No abstract available.

PMID:
16948256
17.

The law of biotechnology: a mystery inside an enigma.

Brown SA.

Healthspan. 1988 May;5(5):7-11. No abstract available.

PMID:
10288655
18.

From Jim to gene and beyond: an odyssey of biologics regulation.

Noguchi PD.

Food Drug Law J. 1996;51(3):367-73. No abstract available.

PMID:
11797713
19.

Nanotechnology and the U.S. Food and Drug Administration.

Marlowe DE.

Stand News. 2005 Jul;33(7):29-31. No abstract available.

PMID:
16237872
20.

Are bioengineered foods safe?. Interview by Larry Thompson.

Henney JE.

FDA Consum. 2000 Jan-Feb;34(1):18-23. No abstract available.

Supplemental Content

Support Center